(Mon810) in Rats As a Model

Total Page:16

File Type:pdf, Size:1020Kb

(Mon810) in Rats As a Model A PROTEOMICS-BASED APPROACH TO STUDYING THE IMPACT OF TRANSGENIC MAIZE (MON810) IN RATS AS A MODEL Asmaa Ali Al-Harbi A thesis submitted for the degree of Doctor of Philosophy (Ph.D.) at Newcastle University School of Biology, Faculty of Science, Agriculture and Engineering October 2015 Table of Contents List of Figures ............................................................................................................. vii List of Tables .................................................................................................................. x List of Appendices ....................................................................................................... xii Acknowledgements ....................................................................................................... xv Declaration .................................................................................................................. xvi Abstract ...................................................................................................................... xvii List of Abbreviations ................................................................................................ xviii Chapter 1. General Introduction ................................................................................... 1 1.1 Genetically modified crops .................................................................................... 1 1.1.1 Types of GM crops ......................................................................................... 2 1.1.2 Commercially growing GM crops .................................................................. 3 1.1.3 Advantages of GM-derived foods .................................................................. 3 Pest resistance ...................................................................................................... 3 Herbicide tolerance .............................................................................................. 4 Disease resistance ................................................................................................ 9 Cold tolerance ...................................................................................................... 9 Drought tolerance/salinity tolerance ................................................................... 9 Nutrition ............................................................................................................. 10 Pharmaceuticals ................................................................................................. 11 Phytoremediation ............................................................................................... 11 1.1.4 Concerns regarding GM foods for human use.............................................. 12 Allergenicity ....................................................................................................... 12 Unknown effects on human health ..................................................................... 12 1.1.5 Environmental concerns ............................................................................... 13 Pesticide resistant crops could be toxic to non-target organisms ..................... 13 Reduced effectiveness of pesticides .................................................................... 13 All of these environmental hazards are compounded by genetic pollution ....... 13 1.1.6 Genetically modified maize/corn .................................................................. 14 Definition of MON 810 ...................................................................................... 14 History of MON 810 ........................................................................................... 16 MON810 is a group of tens of varieties ............................................................. 17 The European stalk borer .................................................................................. 17 i Mode of action of Bt Cry toxins ......................................................................... 18 Yield advantages for the cultivation of the MON810 crop ................................ 19 1.2 Omic based technologies in food safety .............................................................. 22 1.2.1 Assessing the safety of whole foods ............................................................. 23 1.2.2 Can–omics of novel food/feed inform a safety assessment? ........................ 25 Transcriptomics ................................................................................................. 25 Proteomics ......................................................................................................... 26 Metabolomics ..................................................................................................... 30 1.2.3 Use of proteomic based technologies to study toxicology and animal response to stress ................................................................................................... 31 1.3 Aims of the project .............................................................................................. 33 Chapter 2. Materials and Methods .............................................................................. 35 2.1 Materials .............................................................................................................. 35 2.2 Methods ............................................................................................................... 36 2.2.1 Effects of different maize lines on weight gain and food consumption of male Wistar rats ..................................................................................................... 36 Test materials ..................................................................................................... 36 Diet formulation for rat feeding trials ............................................................... 37 Compositional analyses of rat diets ................................................................... 37 Analysis for nutritional composition and environmental contaminants ............ 38 Animals and housing .......................................................................................... 38 Experimental design: 7-day and 28-day Rat Feeding Trials ............................. 38 2.2.2 Isolation of small intestine epithelial cells ................................................... 39 2.2.3 Protein separation and identification ............................................................ 41 Protein extraction from isolated rat intestinal epithelial cells .......................... 41 Determination of protein concentration............................................................ 41 Cleaning up and preparing the samples for 2-D electrophoresis ...................... 44 Two-dimensional gel electrophoresis (2-DE) .................................................... 45 First dimensional electrophoresis (Isoelectric Focusing (IEF)) .................... 45 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) ................................. 46 SDS-PAGE molecular weight standards, broad range .................................. 47 Visualisation of proteins .................................................................................... 50 Image acquisition and analysis .......................................................................... 50 Mass spectrometry based identification of proteins of interest ......................... 51 ii Tryptic in gel digestion for liquid chromatography-mass spectrometry (LC-MS/MS) ................................................................................................... 51 Nanoflow HPLC electrospray tandem mass spectrometry (nLC-ESI- MS/MS) ........................................................................................................... 51 Database search for protein identification ........................................................ 52 2.2.4 In vitro effects of transgenic maize (Bt maize MON810) expressing Cry1Ab protein (Bacillus thuringiensis toxin) on mammalian epithelial cells ..... 52 Test material ...................................................................................................... 52 Protein extraction of maize (MEB307Bt) Cry1Ab MON810 ............................. 53 Immunoassy by Western blotting of test material .............................................. 53 Cell culture methods .......................................................................................... 53 Isolation of epithelial cells from rat small intestine ....................................... 54 Establishment in culture of epithelial cells isolated from rat small intestine and the commercial human epithelial cell line HCT116 ................. 54 Cell count and viability count......................................................................... 55 Subculturing of cells ....................................................................................... 56 Cell staining ................................................................................................... 56 Cryopreservation ............................................................................................ 58 Cell viability assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay) ................................................................. 58 Calibration of growth curve through the Growth Cell Cycle ........................ 59 Determination of exposure time of Bt and non-Bt maize extracts for both IE cells
Recommended publications
  • Mon-810-Pollen
    mon-810-pollen Organisation: Dr. Steisslinger Consulting Country: Germany Type: Consultant a. Assessment: 3. Environmental risk assessment GMO plants do not belong into the environment!!! Safety has never been properly established. I oppose vehemntly any relaease into the environment. Organisation: E3D Country: France Type: Association a. Assessment: Molecular characterisation The implanted genes are truncated and therefore their expression is not identical to that produced and expressed by Bacillus Thurigensis as an insecticide. b. Food Safety Assessment: Toxicology No studies covering a period longer than three months have ever been produced by the breeder (Monsanto). A study over at least two years should have been necessary for the maize to gain appoval. Why is the pollen not tested over two years? Allergenicity Ditto Nutritional assessment Substantial equivalence is a complete fraud, accepted by the ..... of the US Food and Drug Administration. Why? 3. Environmental risk assessment No studies have ever been produced by Monsanto. 4. Conclusions and recommendations Definitive prohibition of any GMO on which a full study spanning at least two years (rats) has not been conducted. 6. Labelling proposal Irelevant. Organisation: Conservation Engineering Ltd Country: United Kingdom Type: Individual a. Assessment: 4. Conclusions and recommendations Please keep GM pollen out of the EU. Reject this proposal and application Organisation: Testbiotech Country: Germany Type: Non Profit Organisation a. Assessment: Molecular characterisation The EFSA risk assessment suffers from a lack of data on the actual Bt content in pollen. The original data from Monsanto are around 20 years old. Since then only very few data were made available. Further, the methods for measuring the Bt content were never evaluated for reliability and comparability (Szecaks, et al., 2011).
    [Show full text]
  • Submission to the French Comimission Du Genie Biomoleculaire
    Submission to the French Comimission du Genie Biomoleculaire Application to Place on the Market Genetically Modified Higher Plants: Insect-Protected Maize (MON 810) by Monsanto Company represented by Monsanto Europe S.A. List of Abbreviations 2,4-D (2,4-dichlorophenoxy)acetic acid APHIS Animal Plant Health Inspection Service bp, Kb Base pairs, kilobase pairs B. t.h. Bacillus thuringiensis subsp. kurstaki CaMV Cauliflower mosaic virus CaMVV E35S 35S promoter with enhancer sequence from CaMV CFR U S. Code of federal regulations CP4 EPSPS EPSPS from Agrobacterium sp. strain CP4 cry JA(b) C"lass I (Lepidoptera-specific) crystal protein gene CTP Chloroplast transit peptide E. coli Escherichica colt ECB European corn borer ELISA Enzyme-linked immunosorbent assay EPA U.S. Environmental Protection Agency EPSPS 5-enolpyruvylshikimate-3-phosphate synthase FDA U.S. Food and Drug Administration GLP Good Laboratory Practices GMO Genetically Modified Organism gox Gene for glyphosate oxidoreductase GOX Glyphosate oxidoreductase hsp70 Intron sequence from maize heat-shock protein 70 IPM Integrated Pest Management kD Kilodaltons N.A. Not analysed N.D. Not detected NOS 3' 3' transcriptional termination sequence from nopaline synthase NPTII Neomycin phosphotransferase II np tll Gene for neomycin phosphotransferase II 0 ri-p UC Bacterial origin of replication from the pUC plasmid PCR Polymerase chain reaction ppm parts per million SSUIA small subunit gene of ribulose-1,5-bisphosphate carboxylase USDA United States Department of Agriculture W/W weight/weight 2 Table of Contents PART A: GENERAL INFORMATION 1. Details of notification ................ .. 7 2. Notifier/manufacturer/importer........ ........ 7 3. Characterization of the GMOs contained in the product.....
    [Show full text]
  • Application for Authorization of NK603 × MON 810 Maize for Cultivation in the European Union Under Regulation (EC) No 1829/2003 on Genetically Modified Food and Feed
    Application for authorization of NK603 × MON 810 maize for cultivation in the European Union under Regulation (EC) No 1829/2003 on genetically modified food and feed Part II Summary October 2005 Part II - Summary A. GENERAL INFORMATION 1. Details of application a) Member State of application The Netherlands b) Notification number Not known at the time of application c) Name of the product (commercial and other names) The Monsanto development code for this genetically modified maize is: NK603 × MON 810. NK603 × MON 810 varieties are marketed under the name of the hybrid variety, in association with the trademarks YieldGard ® Corn Borer with Roundup Ready ® Corn 2, indicating clearly to growers that the hybrid is protected from specific lepidopteran insect pests and that it is tolerant to Roundup ® herbicide. d) Date of acknowledgement of notification Not known at the time of application 2. Applicant a) Name of applicant Monsanto Company, represented by Monsanto Europe S.A./N.V. b) Address of applicant Monsanto Europe S.A./N.V. Monsanto Company Avenue de Tervuren 270-272 800 N. Lindbergh Boulevard B-1150 Brussels St. Louis, Missouri 63167 BELGIUM U.S.A c) Name and address of the person established in the Community who is responsible for the placing on the market, whether it be the manufacturer, the importer or the distributor, if different from the applicant (Commission Decision 2004/204/EC Art 3(a)(ii)) NK603 × MON 810 maize 1 will be cultivated, traded and used in the European Union in the same manner as current commercial maize and by the same growers and operators currently involved in the planting, trade and use of traditional maize.
    [Show full text]
  • Annual Monitoring Report on the Cultivation of MON 810 in 2008
    Annual Monitoring Report on the Cultivation of MON 810 in 2008 Czech Republic, Germany, Portugal, Slovakia, Poland, Romania and Spain Submitted by MONSANTO EUROPE S.A. Dept. Regulatory Affairs Avenue de Tervuren 270-272 Tervurenlaan 270-272 B-1150 Brussels BELGIUM VOLUME 1 OF 1 July 2009 Data protection. This application contains scientific data and other information which are protected in accordance with Art. 31 of Regulation (EC) No 1829/2003. © 2009 Monsanto Company. All Rights Reserved. This document is protected under copyright law. This document is for use only by the regulatory authority to which this has been submitted by Monsanto Company, and only in support of actions requested by Monsanto Company. Any other use of this material, without prior written consent of Monsanto Company, is strictly prohibited. By submitting this document, Monsanto Company does not grant any party or entity any right to license, or to use the information of intellectual property described in this document. EXECUTIVE SUMMARY In 2008, Bt maize was planted in the EU on 107,719 hectares across seven countries (James, 2008). As part of stewardship of the technology, industry has implemented an Insect Resistance Management (IRM) plan to proactively avoid and/or delay the potential development of pest resistance to the Cry protein, as well as a voluntary general surveillance monitoring program. The adherence to these stewardship measures in the context of the cultivation of MON 810 maize in Europe is detailed in the Annual Monitoring Report on the Cultivation of MON 810 in 2008. The planting of MON 810 in the 2008 season was accompanied by a rigorous IRM plan involving three main elements: refuge implementation, monitoring and farmer education.
    [Show full text]
  • Appendix 5.3 MON 810 Literature Review – List of All Hits (June 2016
    Appendix 5.3 MON 810 literature review – List of all hits (June 2016-May 2017) -Web of ScienceTM Core Collection database 12/8/2016 Web of Science [v.5.23] ­ Export Transfer Service Web of Science™ Page 1 (Records 1 ­­ 50) [ 1 ] Record 1 of 50 Title: Ground beetle acquisition of Cry1Ab from plant­ and residue­based food webs Author(s): Andow, DA (Andow, D. A.); Zwahlen, C (Zwahlen, C.) Source: BIOLOGICAL CONTROL Volume: 103 Pages: 204­209 DOI: 10.1016/j.biocontrol.2016.09.009 Published: DEC 2016 Abstract: Ground beetles are significant predators in agricultural habitats. While many studies have characterized effects of Bt maize on various carabid species, few have examined the potential acquisition of Cry toxins from live plants versus plant residue. In this study, we examined how live Bt maize and Bt maize residue affect acquisition of Cry1Ab in six species. Adult beetles were collected live from fields with either current­year Bt maize, one­year­old Bt maize residue, two­year­old Bt maize residue, or fields without any Bt crops or residue for the past two years, and specimens were analyzed using ELISA. Observed Cry1Ab concentrations in the beetles were similar to that reported in previously published studies. Only one specimen of Cyclotrachelus iowensis acquired Cry1Ab from two­year­old maize residue. Three species acquired Cry1Ab from fields with either live plants or plant residue (Cyclotrachelus iowensis, Poecilus lucublandus, Poecilus chalcites), implying participation in both live­plant and residue­based food webs. Two species acquired toxin from fields with live plants, but not from fields with residue (Bembidion quadrimaculatum, Elaphropus incurvus), suggesting participation only in live plant­based food webs.
    [Show full text]
  • U.S. EPA, Pesticide Product Label, MON 863 X MON 810, 10/10/2008
    lv/ro 12-D9~ _, l UNITEO: ATES ENVIRONMENTJ&4;f,,\/ECTION c. _::NCY· i OCT 1 P 2008. Ms. Margaret Wideman Regulatory Affairs Manager Monsanto Company 800 North Lindbergh Blvd St.· Louis, MO 63167 Dear Ms. Wideman: Subject: Your February 15,2008 Amendment Requests to Remove the Expiration Dates for Yie1dGard, Yie1dGard Plus Com, and MON 88017 x -MONB 810 EPA Registration Nos. 524-489, 524-545, and 524-552 The amendments referred to above, .submitted in connection with registration under section 3(c)(7)(A)ofthe Federal Insecticide, Fungicide, and Rodenticide Act, as amended, are acceptable subject to the following comments. 1) For EPA Registration Numbers 524-489,~52*5~r5, and 524-552: ~) The subject plant-incorporated protectant may be combined through conventional breeding with other registered plant-incorporated protectants. that are similarly approved for use in combination, through conventional breeding, with other plant-incorporated protectants to produce inbred com lines and hybrid com varieties with combined pesticidal traits. b) The subject registration will automatically expire on midnight September 30,2010. We are currently unaware of any issues that would preclude a decision to remove the expiration date in the future.. However, due to other statutory priorities, BPPD's review. of the data and information submitted as conditions of registration is ongoing. Therefore, the expiration date is being extended to match that of com rootworm resistant Bt com as an interim measure. c) Refuge requirements do not apply to seed propagation of inbred and hybrid com seed com up to a total of 20,000 acres per county and up to a combined U.S.
    [Show full text]
  • Annual Monitoring Report on the Cultivation of MON 810 in 2016
    Annual monitoring report on the cultivation of MON 810 in 2016 Czech Republic, Portugal, Slovakia, and Spain Submitted by MONSANTO EUROPE S.A. Dept. Regulatory Affairs Avenue de Tervuren 270-272 Tervurenlaan 270-272 B-1150 Brussels BELGIUM September 2017 Data protection. This application contains scientific data and other information which are protected in accordance with Art. 31 of Regulation (EC) No 1829/2003. © 2017 Monsanto Company. All Rights Reserved. This document is protected under national and international copyright law and treaties. This document and any accompanying material are for use only by the regulatory authority to which it has been submitted by Monsanto Company and its affiliates, collectively “Monsanto Company”, and only in support of actions requested by Monsanto Company. Any other use, copying, or transmission, including internet posting, of this document and the materials described in or accompanying this document, without prior consent of Monsanto Company, is strictly prohibited. The intellectual property, information and materials described in or accompanying this document are owned by Monsanto Company, which has filed for or been granted patents on those materials. By submitting this document and any accompanying materials, Monsanto Company does not grant any party or entity any right or license to the information, material or intellectual property described or contained in this submission. TABLE OF CONTENTS TABLE OF CONTENTS...............................................................................................................2
    [Show full text]
  • Federal Register/Vol. 75, No. 164/Wednesday, August 25, 2010
    Federal Register / Vol. 75, No. 164 / Wednesday, August 25, 2010 / Notices 52329 Those persons who are or, may be Dated: August 17, 2010. FOR FURTHER INFORMATION CONTACT: required to conduct testing of chemical Jay S. Ellenberger, Jeannine Kausch, Biopesticides and substances under the Federal Food, Acting Director, Field and External Affairs Pollution Prevention Division (7511P), Drug, and Cosmetics Act (FFDCA), or Division, Office of Pesticide Programs. Office of Pesticide Programs, the Federal Insecticide, Fungicide, and [FR Doc. 2010–20842 Filed 8–24–10; 8:45 a.m.] Environmental Protection Agency, 1200 Rodenticide Act (FIFRA). BILLING CODE 6560–50–S Pennsylvania Ave., NW., Washington, DC 20460–0001; telephone number: B. How Can I Get Copies of this (703) 347–8920; fax number: (703) 305– Document and Other Related ENVIRONMENTAL PROTECTION 0118; e-mail address: Information? AGENCY [email protected]. 1. Docket. EPA has established a SUPPLEMENTARY INFORMATION: docket for this action under docket ID [EPA–HQ–OPP–2010–0699; FRL–8842–8] number EPA–HQ–OPP–2010–0001. I. General Information Corn Event MON 863 and MON 863 x Publicly available docket materials are MON 810; Product Cancellation Order A. Does this Action Apply to Me? available either in the electronic docket for Certain Pesticide Registrations at http://www.regulations.gov, or, if only This action is directed to the public in general, and may be of interest to a available in hard copy, at the Office of AGENCY: Environmental Protection wide range of stakeholders including Pesticide Programs (OPP) Regulatory Agency (EPA). environmental, human health, and Public Docket in Rm.
    [Show full text]
  • Post Market Environmental Monitoring Plan for Cultivation of Maize MON 810 in the EU
    Post Market Environmental Monitoring Plan for cultivation of maize MON 810 in the EU Table of contents 1 INTRODUCTION ......................................................................................................................................... 3 2 RESPONSIBILITIES ................................................................................................................................... 4 3 CASE-SPECIFIC MONITORING .............................................................................................................. 4 3.1 APPROACH ............................................................................................................................................... 4 3.2 MONITORING FOR RESISTANCE EVOLUTION OF LEPIDOPTERAN TARGET PESTS TO THE CRY1AB PROTEIN 5 3.2.1 Time period ..................................................................................................................................... 5 3.2.2 Monitoring strategy ......................................................................................................................... 5 3.2.2.1 Establishment of baseline to implement the monitoring strategy ................................................................ 5 3.2.2.2 Measurement of changes in susceptibility ................................................................................................... 5 3.2.2.3 Detection limit of resistance allele frequency .............................................................................................. 5 3.2.2.4 Field
    [Show full text]
  • Wto Law and Genetically Modified Products
    135 EAAE Seminar Challenges for the Global Agricultural Trade Regime after Doha WTO LAW AND GENETICALLY MODIFIED PRODUCTS Tatjana Papić Brankov Institute of Agricultural Economics, Belgrade, Serbia [email protected] Koviljko Lovre University of Novi Sad, Faculty of Economics in Subotica, Serbia [email protected] Abstract: The paper discusses the mechanisms by which World Trade Organization (WTO) influence the diffusion of genetically modified (GM) products. We have analyzed the connection between the international trade of GM products and the three WTO Agreements: the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), the Sanitary and Phytosanitary (SPS) Agreement and the General Agreement on Trade in Services (GATS). It can be concluded that the mechanisms of the WTO organization are often used as instruments of threat to nations seeking to ban imports of GM food. In failing to acknowledge and support the precautionary principle, the WTO may have further weakened its authority to make decisions affecting the human health and environment and, in so doing, lessened its legitimacy in the world arena. Keywords: WTO, GM products, TRIPS, SPS, GATS INTRODUCTION Genetically modified organisms (GMOs) and foods produced from them- genetically modified (GM) food is highly politicized issues observing the health, economic and environmental aspects. Between 1996 and 2012 the global area planted with GM crops increased by 100 fold, in 2012 covering some 170.3 million hectares (James, 2012). From the very beginning US are major producer of GM crops, with 69.5 million hectares, which produce 95% of the nation's sugar beets, 94% of the soybeans, 90% of the cotton and 88% of the feed corn1.
    [Show full text]
  • 06 29801P Com.Pdf
    Attachment Finding of no significant impact Response to comments APHIS No. 06-298-01p On December 13, 2007, APHIS published a notice in the Federal Register (72 FR 70817- 70819, Docket no. 2007-0030) announcing the availability of the MON 89034 draft EA for public review and comment for a 60-day comment period, ending February11, 2008. APHIS reviewed the petition to determine if the genetically engineered (GE) corn should continue to be considered a regulated article under the APHIS biotechnology regulations found at 7 CFR Part 340. In order for a GE organism to be considered a regulated article under these regulations, the organism must pose a plant pest risk and be modified by recombinant DNA techniques (genetic engineering under the definition of the regulation). Prior to making a decision on a petition for APHIS to grant nonregulated status for a GE organism, APHIS usually prepares an EA to evaluate the significance of impacts on the environment arising from a decision to grant nonregulated status. APHIS prepares the EA as part of its obligation, like other Federal agencies, to meet the requirements of the National Environmental Policy Act of 1969 (NEPA). As part of a petition, APHIS considers public comments on the proposed deregulation as well as the EA that APHIS prepares pursuant to NEPA. APHIS received 29 comments; 24 in opposition and 5 in favor of the deregulation of MON 89034. Of the five supportive comments, 3 were from academia and 2 were from non-profit corn grower associations. Reasons given for supporting deregulation include (but are not limited to) the proven safety of the technology, improved control of corn earworm and fall armyworm relative to single gene events, reduction in mycotoxins, and the reduced possibility of development of resistance afforded by the pyramided genes in this product.
    [Show full text]
  • Diapositiva 1
    Debate científico sobre Transgénicos Academia Nacional de Ciencias Debate científico sobre Transgénicos PROS Regul Toxicol Pharmacol. 2011 Apr;59(3):437-44. Epub 2011 Feb 5. Proteomic analysis of known and candidate rice allergens between non-transgenic and transgenic plants. Satoh R, Nakamura R, Komatsu A, Oshima M, Teshima R. Division of Novel Foods and Immunochemistry, National Institute of Health Sciences, 1-18- 1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan. Salt-soluble proteins extracted from non-transgenic and transgenic rice were evaluated for the presence of known and potential allergens by proteomic techniques. Quantitative analysis of 19, 52, and 63 kDa globulins with protein-specific-animal sera showed no significant differences in the expression of these proteins between the transgenic rice and non- transgenic rice. These results indicate that none of the known or novel endogenous IgE-binding proteins detected in this study appear to be altered by genetic modification Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. Epub 2008 Feb 13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials.Collaborators (37) Alink G, Barlow S, Cockburn A, Flachowsky G, Knudsen I, Kuiper H, Massin DP, Pascal G, Peijnenburg A, Phipps R, Pöting A, Poulsen M, Seinen W, Spielmann H, van Loveren H, Wal JM, Williams A, Andersson HC, Arpaia S, Bartsch D, Casacuberta J, Davies H, De Loose M, Hendriksen N, Herman L, Kärenlampi S, Kiss J, Kryspin-Sørensen I, Kuiper H, Nes I, Panopoulos N, Perry J, Pöting A, Schiemann J, Seinen W, Sweet J, Wal JM.
    [Show full text]